Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Next-generation Sequencing

Next-generation Sequencing

The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....

Modern Molecular Taxonomy

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas.

Clinical cancer research : an official journal of the American Association for Cancer Research·2021

Same author

Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.

Investigational new drugs·2021

Same author

Artificial intelligence in clinical and translational science: Successes, challenges and opportunities.

Clinical and translational science·2021

Same author

Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified.

Cancer·2021

Same author

<i>RAC1</i> Alterations Induce Acquired Dabrafenib Resistance in Association with Anaplastic Transformation in a Papillary Thyroid Cancer Patient.

Cancers·2021

Same author

Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.

Investigational new drugs·2021

Same journal

RankVar: machine learning-based variant ranking and reinterpretation for rare genetic diseases.

Genome medicine·2026

Same journal

Multi-omics profiles of sex hormone-binding globulin are associated with subclinical atherosclerosis in men with HIV.

Genome medicine·2026

Same journal

Multi-modal data integration reveals functionally credible predictive biomarkers in ovarian cancer.

Genome medicine·2026

Same journal

Human cancer genomes harbor the mutational signature of tobacco-specific nitrosamines NNN and NNK.

Genome medicine·2026

Same journal

Identification and functional characterization of regulatory variants in DPP9 associated with COVID-19 severity.

Genome medicine·2026

Same journal

De novo variants in NPTN cause a neurodevelopmental disorder with autism and neuroplastin-PMCA hypofunction.

Genome medicine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Apr 14, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

ClinSeK: a targeted variant characterization framework for clinical sequencing.

Wanding Zhou¹, Hao Zhao¹, Zechen Chong¹

¹Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.

Genome Medicine

|April 29, 2015

Summary

This summary is machine-generated.

A new framework called ClinSeK enables rapid and accurate genomic variant characterization for clinical applications. This tool efficiently analyzes high-throughput sequencing data to identify clinically relevant genetic variants in cancer patients.

More Related Videos

Targeted DNA Methylation Analysis by Next-generation Sequencing

Targeted DNA Methylation Analysis by Next-generation Sequencing

Published on: February 24, 2015

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Related Experiment Videos

Last Updated: Apr 14, 2026

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Targeted DNA Methylation Analysis by Next-generation Sequencing

Targeted DNA Methylation Analysis by Next-generation Sequencing

Published on: February 24, 2015

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Area of Science:

Genomics
Bioinformatics
Clinical Diagnostics

Background:

Genomic analysis for patient care requires sensitive, rapid, and unambiguous characterization of known clinical variants.
Existing variant discovery methods are not optimized for targeted clinical applications, demanding examination of every base in sequencing data.
Detecting multiple and rare variants from heterogeneous samples presents a significant challenge in clinical genomics.

Purpose of the Study:

To develop a novel variant characterization framework, ClinSeK, for targeted analysis of high-throughput sequencing data.
To create a robust tool capable of characterizing a wide spectrum of genetic variants, from single nucleotide variations to large-scale genomic rearrangements.
To improve the accuracy, runtime, and storage efficiency of variant characterization for clinical applications.

Main Methods:

Developed ClinSeK, a novel framework for targeted analysis of relevant reads from high-throughput sequencing data.
Designed ClinSeK for efficient targeted short read alignment.
Evaluated ClinSeK's performance on over a thousand cancer patient samples.

Main Results:

ClinSeK demonstrated substantively better performance compared to existing variant discovery tools for clinical applications.
The framework showed improvements in accuracy, runtime, and disk storage requirements.
ClinSeK successfully characterized a wide spectrum of genetic variants, including single nucleotide variations and large-scale genomic rearrangement breakpoints.

Conclusions:

ClinSeK provides a robust and efficient solution for characterizing clinically relevant genomic variants.
The framework significantly enhances the performance of genomic analysis in clinical settings, particularly for cancer patient care.
ClinSeK is freely available for academic use, promoting advancements in clinical genomics.